| 2024 |
| Peer Reviewed Publications |
| Wajiha Bano, Pulli E., Cantonas L., SorsaA., Hämäläinen J., Karlsson H., Karlsson L., Saukko E., Sainio T., Peuna A., Korja R., Aro M., Paavo H.T. Leppänen, Jetro J. Tuulari, Harri Merisaaria:
Implementing ABCD study® MRI sequences for multi-site cohort studies: practical guide to necessary steps, preprocessing methods, and challenges.
MethodsX. 2024 Jun 1:102789.
|
| Jambor, I., Steiner, A., Pesola, M., Gardberg, M., Frantzén, J., Jokinen, P., Liimatainen, T., Minn, H., Aronen, H. and Merisaari, H.:
Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
Plos one. 2024 Apr 1;19(4):e0296958.
|
| Setänen, S., Merisaari, H., Saunavaara, V., Uusitalo, K., Lahti, K., Ngum, P., Haataja, L. and Parkkola, R.:
Major brain injuries at term continue to influence DTI parameters in adolescents born very preterm: a 13-year follow-up study. Acta Radiologica. 2024 May 17:02841851241252716.
|
| Rosberg, A., Merisaari, H., Lewis, J.D., Hashempour, N., Lukkarinen, M., Rasmussen, J.M., Scheinin, N.M., Karlsson, L., Karlsson, H. and Tuulari, J.J.:
Associations between maternal pre-pregnancy BMI and infant striatal mean diffusivity. BMC medicine. 2024 Mar 25;22(1):140.
|
| Buss, C., Tuulari, J.J., Nolvi, S., Thompson, P.M., Merisaari, H., Lavonius, M., Karlsson, L., Gyllenhammer, L.E., Lindsay, K.L., O’Connor, T.G. and Koletzko, B.:
Intergenerational transmission of obesity risk by fetal programming of hypothalamus development. Psychoneuroendocrinology. 2024 Feb 1;160:106744.
|
| 2023 |
| Peer Reviewed Publications |
| Mariani Wigley ILC, Björnsdotter M, Scheinin NM, Merisaari H, Saunavaara J, Parkkola R, Bonichini S, Montirosso R, Karlsson L, Karlsson H, Tuulari JJ:
Infants' sex affects neural responses to affective touch in early infancy. Dev Psychobiol. 2023 Nov; 65(7):e22419.
|
| Merisaari H, Karlsson L, Scheinin NM, Shulist SJ, Lewis JD, Karlsson H, Tuulari JJ:
Effect of number of diffusion encoding directions in neonatal diffusion tensor imaging using Tract-Based Spatial Statistical analysis. Eur J Neurosci. 2023 Oct; 58(8):3827-3837.
|
| Pulli EP, Nolvi S, Eskola E, Nordenswan E, Holmberg E, Copeland A, Kumpulainen V, Silver E, Merisaari H, Saunavaara J, Parkkola R, Lähdesmäki T, Saukko E, Kataja EL, Korja R, Karlsson L, Karlsson H, Tuulari JJ:
Structural brain correlates of non-verbal cognitive ability in 5-year-old children: Findings from the FinnBrain birth cohort study. Hum Brain Mapp. 2023 Aug 22.
|
| Dai Z, Jambor I, Taimen P, Pantelic M, Elshaikh M, Dabaja A, Rogers C, Ettala O, Boström PJ, Aronen HJ, Merisaari H, Ning Wen:
Prostate cancer detection and segmentation on MRI using non‐local mask R‐CNN with histopathological ground truth. Medical physics. 2023 Jun 26.
|
| Hashempour N, Tuulari JJ, Merisaari H, Acosta H, Lewis JD, Pelto J, Scheinin NM, Fonov VS, Collins DL, Lehtola SJ, Saunavaara J, Lähdesmäki T, Parkkola R, Karlsson L, Karlsson H:
Prenatal maternal depressive symptoms are associated with neonatal left amygdala microstructure in a sex‐dependent way. European Journal of Neuroscience. 2023 May 2.
|
| Kumpulainen V, Merisaari H, Silver E, Copeland A, Pulli EP, Lewis JD, Saukko E, Shulist SJ, Saunavaara J, Parkkola R, Lähdesmäki T, Karlsson L, Karlsson H, Tuulari JJ:
Sex differences, asymmetry, and age‐related white matter development in infants and 5‐year‐olds as assessed with tract‐based spatial statistics. Human Brain Mapping. 2023 May;44(7):2712-25.
|
| Bucci M, Iozzo P, Merisaari H, Huovinen V, Lipponen H, Räikkönen K, Parkkola R, Salonen M, Sandboge S, Eriksson JG, Nummenmaa L, Nuutila P:
Resistance Training Increases White Matter Density in Frail Elderly Women. Journal of clinical medicine. 2023 Apr 4;12(7):2684.
|
| Acosta H, Kantojärvi K, Tuulari JJ, Lewis JD, Hashempour N, Scheinin NM, Lehtola SJ, Nolvi S, Fonov VS, Collins DL, Evans AC, Parkkola R, Lähdesmäki T, Saunavaara J, Merisaari H, Karlsson L, Paunio T, Karlsson H:
Association of cumulative prenatal adversity with infant subcortical structure volumes and child problem behavior and its moderation by a coexpression polygenic risk score of the serotonin system.
Development and Psychopathology. 2023 Apr 3:1-6.
|
| Rasmussen JM, Tuulari JJ, Nolvi S, Thompson PM, Merisaari H, Lavonius M, Karlsson L, Entringer S, Wadhwa PD, Karlsson H, Buss C:
Maternal pre-pregnancy body mass index is associated with newborn offspring hypothalamic mean diffusivity: a prospective dual-cohort study.
BMC medicine. 2023 Feb;21(1):1-3.
|
| Beheshti M, Taimen P, Kemppainen J, Jambor I, Müller A, Loidl W, Kähkönen E, Käkelä M, Berndt M, Stephens AW, Minn H, Langsteger W:
Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F] fluoromethylcholine PET-CT and multiparametric MRI—A phase I/II study.
European Radiology. 2023 Jan;33(1):472-82.
|
| Happonen T, Nyman M, Ylikotila P, Merisaari H, Mattila K, Hirvonen J:
Diagnostic yield of emergency MRI in non-traumatic headache. Neuroradiology. 2023 Jan;65(1):89-96.
|
| 2022 |
| Peer Reviewed Publications |
| Rosberg A, Tuulari JJ, Kumpulainen V, Lukkarinen M, Pulli EP, Silver E, Copeland A, Saukko E, Saunavaara J, Lewis JD, Karlsson L, Karlsson H, Merisaari H:
Test–retest reliability of diffusion tensor imaging scalars in 5‐year‐olds. Human Brain Mapping. 2022 Nov;43(16):4984-94.
|
| Silver E, Pulli EP, Kataja EL, Kumpulainen V, Copeland A, Saukko E, Saunavaara J, Merisaari H, Lähdesmäki T, Parkkola R, Karlsson L:
Prenatal and early-life environmental factors, family demographics and cortical brain anatomy in 5-year-olds: an MRI study from FinnBrain Birth Cohort.
Brain Imaging and Behavior. 2022 Oct;16(5):2097-109.
|
| Numminen R, Montoya Perez I, Jambor I, Pahikkala T, Airola A:
Quicksort leave-pair-out cross-validation for ROC curve analysis. Computational Statistics. 2022 Oct 6:1-7
|
| Kumpulainen V, Merisaari H, Copeland A, Silver E, Pulli EP, Lewis JD, Saukko E, Saunavaara J, Karlsson L, Karlsson H, Tuulari JJ:
Effect of number of diffusion‐encoding directions in diffusion metrics of 5‐year‐olds using tract‐based spatial statistical analysis.
European Journal of Neuroscience. 2022 Sep;56(6):4843-68.
|
| Lidauer K, Pulli EP, Copeland A, Silver E, Kumpulainen V, Hashempour N, Merisaari H, Saunavaara J, Parkkola R, Lähdesmäki T, Saukko E:
Subcortical and hippocampal brain segmentation in 5‐year‐old children: Validation of FSL‐FIRST and FreeSurfer against manual segmentation.
European Journal of Neuroscience. 2022 Sep;56(5):4619-41.
|
| Peters M, Eldred-Evans D, Kurver P, Falagario UG, Connor MJ, Shah TT, Verhoeff JJ, Taimen P, Aronen HJ, Knaapila J, Montoya Perez I, Ettala O, Stabile A, Gandaglia G, Fossati N, Martini A
Cucchiara V, Brigant A, Lantz A, Picker W, Skaaheim E, T Nordström, Bertoncelli Tanaka M, Deepika R, Bass E, S.N.van Rossum P, Wong K, Tam H, Winkler M, Gordon S, Qazi H, Boström PJ, Jambor I, Ahmed HU:
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in
Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert≥ 3 Lesion:
Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score. European Urology. 2022 Aug 11.
|
| Parekh S, Ratnani P, Falagario U, Lundon D, Kewlani D, Nasri J, Dovey Z, Stroumbakis D, Ranti D, Grauer R, Sobotka S, Pedraza A, Wagaskara V, Mistry L, Jambor I,
Lantz A, Ettala O, Stabile A, Taimen P, Aronen HJ, Knaapila J, Montoya Perez I, Gandaglia G, Martini A, Picker W, Haug E, Cormio L, Nordström T, Brigant A, Boström PJ,
Carrieri J, Haines K, Gorin MA, Wiklund P, Menon M, Ash T:
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer:
Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database,
and European Randomized Study of Screening for Prostate Cancer Risk Calculator. European Urology Open Science. 2022 Jul 1;41:45-54.
|
| Pulli EP, Silver E, Kumpulainen V, Copeland A, Merisaari H, Saunavaara J, Parkkola R, Lähdesmäki T, Saukko E, Nolvi S, Kataja EL:
Feasibility of FreeSurfer processing for T1-weighted brain images of 5-year-olds: semiautomated protocol of FinnBrain Neuroimaging Lab.
Frontiers in Neuroscience. 2022 May 2;16:874062.
|
| Chakravarty D, Ratnani P, Huang L, Dovey Z, Sobotka S, Berryhill R, Merisaari H, Al Shaarani M, Rai R, Jambor I, Yadav KK:
Association between incidental pelvic inflammation and aggressive prostate cancer. Cancers. 2022 May 31;14(11):2734.
|
| Ettala O, Jambor I, Montoya Perez I, Seppänen M, Kaipia A, Seikkula H, Syvänen KT, Taimen P,
Verho J, Steiner A, Saunavaara J, Saukko E, Löyttyniemi E, Sjoberg DD, Vickers A, Aronen H, Boström PJ:
Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a
suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V. 2.0). BMJ open. 2022 Apr 1;12(4):e053118.
|
| Arvola S, Seppänen M, Malaspina S, Mätzke S, Raiko J, Timonen KL, Ettala O, Jambor I, Anttinen M, Kuisma A, Löyttyniemi E:
Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
Nuclear Medicine Communications. 2022 Feb 7;43(5):510-7.
|
| Isaacs AM, Neil JJ, McAllister JP, Dahiya S, Castaneyra-Ruiz L, Merisaari H, Botteron HE, Alexopoulos D, George A, Sun P, Morales DM:
Microstructural periventricular white matter injury in post-hemorrhagic ventricular dilatation. Neurology. 2022 Jan 25;98(4):e364-75.
|
| 2021 |
| Peer Reviewed Publications |
| Merisaari H, Federau C:
Signal to noise and b-value analysis for optimal intra-voxel incoherent motion imaging in the brain. Plos one. 2021 Sep 23;16(9):e0257545.
|
| Montoya Perez I, Merisaari H, Jambor I, Ettala O, Taimen P, Knaapila J, Kekki H, Khan FL, Syrjälä E, Steiner A, Syvänen KT, Verho J, Seppänen M, Rannikko A, Riikonen J, Mirtti T, Lamminen T, Saunavaara J, Falagario U, Martini A, Pahikkala T, Pettersson K, Boström PJ, Aronen HJ:
Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer.
J Magn Reson Imaging. 2021 Jul 5. doi: 10.1002/jmri.27811.
|
| Dovey Z, Beksac T, Ratnani P, Roshandel R, Parekh S, Falagario U, Sobotka S, Deepshisha K, Jambor I, Lewis S, Haines K, Tewari AK:
Unified model involving Genomics, MRI and PSA density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer.
Cancer Reports. 2021 In press.
|
| Merisaari H, Laakso H, Liljenbäck H, Virtanen H, Aronen HJ, Minn H, Poutanen M, Roivainen A, Liimatainen T, Jambor I:
Statistical evaluation of different mathematical models for diffusion weighted imaging of prostate cancer xenografts in mice.
Front Oncol. 2021 May 26;11:583921. PMID: 34123770
|
| Leo P, Janowczyk A, Elliott R, Janakid N, Bera K, Shiradkar R, Farre X, Fu P, El-Fahmawi A, Shahaiti M, Kim J, Lee D, Yamoah K, Rebbeck TR, Khani F, Robinson BD, Eklund L, Jambor I, Merisaari H, Ettala O, Taimen P, Aronen HJ, Bostromn PJ, Tewari A, Magi-Galluzzi C, Kleins E, Purysko A, Shihj ANC, Feldman M, Guptau S, Lal P, Madabhushia A:
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.
NPJ Precis Oncol. 2021 May 3;5(1):35
|
| Malaspina S, Anttinen M, Taimen P, Jambor I, Sandell M, Rinta-Kiikka I, Kajander S, Schildt J, Saukko E, Noponen T, Saunavaara J, Dean PB, Sequeiros RB, Aronen HJ, Kemppainen J, Seppänen M, Boström PJ, Ettala O:
Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI using diffusion-weighted imaging and CT in primary nodal staging of prostate cancer.
Eur J Nucl Med Mol Imaging. 2021 Mar 13. doi: 10.1007/s00259-021-05296-1. PMID: 33715033
|
| Jambor I, Steiner A, Pesola M, Liimatainen T, Sucksdorff M, Rissanen E, Airas L, Aronen HJ, Merisaari H:
Whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging in healthy volunteers and patients with multiple sclerosis: initial findings.
J Magn Reson Imaging.2021 Mar 6. doi: 10.1002/jmri.2758. PMID: 33675564
|
| Laakso H, Ylä‐Herttuala E, Sierra A, Jambor I, Poutanen M, Liljenbäck H, Virtanen H, Merisaari H, Aronen H, Minn H, Roivainen A, Liimatainen T:
Docetaxel chemotherapy response in PC3 prostate cancer mouse model detected by rotating frame relaxations and water diffusion. NMR Biomed. 2021 Apr;34(4):e4483 PMID: 33543563
|
| Falagario UG, Jambor I, Lantz A, Ettala O, Stabile A, Taimen P, Aronen HJ, Knaapila J, Montoya Perez I, Gandaglia G, Fossati N, Martini A, Cucchiara V, Picker W, Haug E,
Ratnani P, Haines K, Lewis S, Sujit N, Selvaggio O, Sanguedolce F, Macarini L, Cormio L, Nordström T, Tewari A, Briganti A, Boström PJ, Carrieri G:
Combined use of PSA density and Magnetic Resonance Imaging for prostate biopsy decision planning: Retrospective multi-institutional study using the PRostate Mri Outcome Database (PROMOD).
Eur Urol Oncol. 2020 Sep 21;S2588-9311(20)30142-5. PMID: 32972896
|
| Falagario UG, Lantz A, Jambor I, Martini A, Ratnani P, Wagaskar V, Treacy PJ, Veccia A, Bravi CA, Bashorun HO, Phillip D, Lewis S, Haines K, Cormio L,
Carrieri G, Tewari A.:
Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion.
Int J Urol. 2021 Jan;28(1):47-52. PMID: 32985040
|
| 2020 |
| Peer Reviewed Publications |
| Lantz A, Falagario UG, Ratnani P, Jambor I, Dovey Z, Martini A, Lewis S, Lundon D, Nair S,
Phillip D, Haines K, Cormio L, Carrieri G, Kryprianou N, Tewari A:
Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings.
Eur Urol Oncol. 2020 Sep 2;S2588-9311(20)30125-5. PMID: 32778912
|
| Falagario U, Jambor I, Taimen P, Syvänen KT, Kähkönen E, Merisaari H, Perez IM, Knaapila J,
Stainer A, Verho J, Tewari A, Aronen HJ, Carrieri G, Boström PJ, Ettala O:
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing MRI-targeted biopsy: Multi-institutional external validation study.
World J Urol. 2020 Aug 10. doi: 10.1007/s00345-020-03393-8. PMID: 32778912
|
| Hiremath A, Shiradkar R, Merisaari H, Prasanna P, Ettala O, Taimen P, Aronen HJ, Boström PJ, Jambor I, Madabhushi A.:
Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.
Eur Radiol. 2020 Jul 23. doi: 10.1007/s00330-020-07065-4. PMID: 32700021
|
| Anttinen M, Ettala O, Malaspina S, Jambor I, Sandell M, Kajander S, Rinta-Kiikka I, Schildt J, Saukko E, Rautio P, Timonen KL, Matikainen T, Noponen T, Saunavaara J, Löyttyniemi E, Taimen P, Kemppainen J, Dean PB, Blanco Sequeiros R, Aronen HJ, Seppänen M, Boström PJ:
Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.
Eur Urol Oncol. 2020 Jul 13 doi: 10.1016/j.euo.2020.06.012. PMID: 32675047
|
| Movahedi P, Merisaari H, Perez IM, Taimen P, Kemppainen J, Kuisma A, Eskola O, Teuho J, Saunavaara J, Pesola M, Kähkönen E, Ettala O,
Liimatainen T, Pahikkala T, Boström PJ, Aronen HJ, Minn H, Jambor I.
Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI." Scientific Reports 10, no. 1 (2020): 1-11.
|
| Knaapila J, Jambor I, Ettala O, Taimen P, Verho J, Perez IM, Kiviniemi A,
Pahikkala T, Merisaari H, Lamminen T, Saunavaara J, Aronen HJ, Syvänen KT, Boström PJ.
Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies.
European Urology Focus (2020).
|
| Rajasilta O, Tuulari J, Björnsdotter M, Scheinin NM, Lehtola SJ, Saunavaara J, Häkkinen S, Merisaari H, Parkkola R, Lähdesmäki T and Karlsson L.
Resting=state networks of the neonate brain identified using independent component analysis.
Dev Neurobiol. 2020 Apr 8. doi: 10.1002/dneu.22742.
|
| Falagario UG, Jambor I, Ratnani P, Martini A, Treacy PJ, Wajswol E, Lantz A, Papastefanou G, Weil R, Phillip D, Lewis S, Haines K, Cormio L, Carrieri G, Kyprianou N, Wiklund P, Tewari AK.
Performance of prostate multiparametric MRI for prediction of prostate cancer extraprostatic extension according to NCCN risk categories: implication for surgical planning.
Minerva Urol Nefrol. 2020 Mar 16. doi: 10.23736/S0393-2249.20.03688-7.
|
| Falagario U, Ratnani P, Lantz A, Jambor I, Dovey Z, Verma A, Treacy PJ, Sobotka S, Martini A, Bashorun H, Ashan M, Wagaskar VG, Lewis S, Cormio L, Carrieri G, Kyprianou N, Mohamed N, Tewari A
Staging Accuracy of Multiparametric MRI in Caucasian and African American Patients Undergoing Radical Prostatectomy.
J Urol. 2020 Jan 24:101097JU0000000000000774. doi: 10.1097/JU.0000000000000774
|
| Knaapila J, Autio V, Jambor I, Ettala O, Verho J, Kiviniemi A, Taimen P, Perez IM, Aronen HJ, Syvänen KT, Boström PJ.
Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men.
Scandinavian Journal of Urology (2020): 1-7.
|
| 2019 |
| Peer Reviewed Publications |
| Merisaari H, Taimen P, Shiradkar R, Ettala O, Pesola M, Saunavaara J, Boström PJ, Madabhushi A, Aronen HJ, Jambor I.
Repeatability of radiomics and machine learning: Short-term repeatability study of 112 patients with prostate cancer using Diffusion Weighted Imaging
Magn Reson Med. 2020 Jun;83(6):2293-2309.
|
| Perez IM, Jambor I, Kauko T, Verho J, Ettala O, Falagario U, Merisaari H, KiviniemiA, Taimen P, Syvänen KT,
Knaapila J, Seppänen M, Rannikko A, Riikonen J, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Boström PJ, Aronen HJ.
Qualitative and quantitative reporting of a unique biparametric MRI: Towards biparametric MRI‐based nomograms for prediction of prostate biopsy outcome in men with a clinical suspicion of prostate cancer (IMPROD and MULTI‐IMPROD trials).
Journal of Magnetic Resonance Imaging (2019).
|
| Perez IM, Jambor I, Pahikkala T, Airola A, Merisaari H, Saunavaara J, Alinezhad S, Väänänen R, Tallgrén T, Verho J, Kiviniemi A, Ettala O, Knaapila J,
Syvänen KT, Kallajoki M, Vainio P, Aronen HJ, Pettersson K, Boström PJ, Taimen P.
Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine‐Learning Techniques.
Journal of Magnetic Resonance Imaging 51, no. 5 (2020): 1540-1553.
|
| Hashempour N, Tuulari JJ, Merisaari H, Lidauer K, Luukkonen I, Petteri SJ, Parkkola R, Lähdesmäki T, Lehtola S, Keskinen M, Lewis JD.
A novel approach for manual segmentation of the amygdala and hippocampus in neonate MRI.
Front Neurosci. 2019 Sep 24;13:1025.
|
| Jambor I, Falagario UG, Ratnani P, Perez IM, Demir K, Merisaari H, Sobotka S, Haines GK, Martini A, Beksac AT, Lewis S, Pahikkala T, Wiklund P, Nair S, Tewari A.
Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Journal of Magnetic Resonance Imaging 51, no. 4 (2020): 1075-1085.
|
| Falagario UG, Martini A, Wajswol E, Treacy PJ, Ratnani P, Jambor I, Anastos H, Lewis S, Haines K, Cormio L, Carrieri G, Rastinehad AR, Wiklund P, Tewari A.
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density,
4Kscore and Risk Calculators.Eur Urol Oncol. 2019 Sep 20:S2588-9311(19)30141-5.
|
| Knaapila J, Jambor I, Perez IM, Ettala O, Taimen P, Verho J, Kiviniemi A, Pahikkala T, Merisaari H, Lamminen T, Saunavaara J, Aronen HJ, Syvänen KT, Boström PJ.
Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study.
Eur Urol Oncol. 2019 Sep 6;S2588-9311(19)30134-8 |
| Toivonen J, Perez IM, Movahedi P, Merisaari H, Pesola M, Taimen P, Boström PJ, Pohjankukka J, Kiviniemi A, Pahikkala T, Aronen HJ, Jambor I.
Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization.
PLoS One. 2019 Jul 8;14(7):e0217702.
|
| Jambor I, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ.
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.
PLoS Med. 2019 Jun 3;16(6):e1002813.
|
| Saarinen I, Jambor I, Kim M, Kuisma A, Kemppainen J, Merisaari H, Eskola O, Koskenniemi AR, Perez IM, Boström P, Taimen P, Minn H.
Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.
EJNMMI Res. 2019 May 31;9(1):50.
|
| Merisaari H, Jambor I, Ettala O, Boström PJ, Perez IM, Verho J, Kiviniemi A, Syvänen K, Kähkönen E, Eklund L, Pahikkala T, Vainio P, Saunavaara J, Aronen HJ, Taimen P.
IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.
J Magn Reson Imaging. 2019 Mar 22. doi: 10.1002/jmri.26727
|
| Merisaari H, Tuulari JJ, Karlsson L, Scheinin NM, Parkkola R, Saunavaara J, Lähdesmäki T, Lehtola SJ, Keskinen M, Lewis JD, Evans AC, Karlsson H.
Test-retest reliability of Diffusion Tensor Imaging metrics in neonates. Neuroimage. 2019 Aug 15;197:598-607.
|
| Pulli EP, Kumpulainen V, Kasurinen JH, Korja R, Merisaari H, Karlsson L, Parkkola R, Saunavaara J, Lähdesmäki T, Scheinin NM, Karlsson H, Tuulari JJ.
Prenatal exposures and infant brain: Review of magnetic resonance imaging studies and a population description analysis.
Hum Brain Mapp. 2019 Apr 15;40(6):1987-2000.
|
| Lehtola SJ, Tuulari JJ, Karlsson L, Parkkola R, Merisaari H, Saunavaara J, Lähdesmäki T, Scheinin NM, Karlsson H.
Associations of age and sex with brain volumes and asymmetry in 2-5-week-old infants.
Brain Struct Funct. 2019 Jan;224(1):501-513.
|
| Laurikainen H, Tuominen L, Tikka M, Merisaari H, Armio RL, Sormunen E, Borgan F, Veronese M, Howes O, Haaparanta-Solin M, Solin O, Hietala J; METSY group.
Sex difference in brain CB1 receptor availability in man. Neuroimage. 2019 Jan 1;184:834-842.
|
| Tuulari JJ, Scheinin NM, Lehtola S, Merisaari H, Saunavaara J, Parkkola R, Sehlstedt I, Karlsson L, Karlsson H, Björnsdotter M.
Neural correlates of gentle skin stroking in early infancy. Dev Cogn Neurosci. 2019 Feb;35:36-41.
|
| Arvola S, Jambor I, Kuisma A, Kemppainen J, Kajander S, Seppänen M, Noponen T.
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer.
EJNMMI Res. 2019 Jan 24;9(1):6.
|
| Abstracts |
| Jambor I, Verho J, Otto Ettala, Knaapila J, Taimen P, Syvänen K, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki K, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ.
Prospective multi-institutional validation of IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (MULTI- IMPROD trial).
ISMRM, Montreal, Canada, 2019
|
| Perez IM, Pahikkala T, Airola A, Merisaari H, Taimen P, Alinezhad S, Verho J, Ettala O, Saunavaara J, Pettersson K, Boström PJ, Aronen HJ, Jambor I.
Prostate cancer detection in men with a clinical suspicion prostate cancer using IMPROD biparametric MRI and expression of 11 genes (IMPROD trial, #opensourcetrial): evaluation using machine learning methods.
ISMRM, Montreal, Canada, 2019
|
| Jambor I, Perez IM, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Aronen HJ, Boström PJ.
Development and external validation of IMPROD biparametric MRI- based nomogram for the prediction of prostate biopsy outcome in men with a clinical suspicion of prostate cancer (IMPROD and MULTI- IMPROD trials, #opensourcetrial).
ISMRM, Montreal, Canada, 2019
|
| Merisaari H, Shiradkar R, Toivonen J, Hiremath A, Khorrami M, Perez IM, Pahikkala T, Taimen P, Verho J, Boström PJ, Aronen HJ, Madabhushi A, Jambor I.
Repeatability of radiomic features for prostate cancer diffusion weighted imaging obtained using b-values up to 2000 s/mm2.
ISMRM, Montreal, Canada, 2019
|
|
|
| 2018 |
| Peer Reviewed Publications |
| Salminen A, Jambor I, Merisaari H, Ettala O, Virtanen J, Koskinen I, Veskimae E, Sairanen J, Taimen P, Kemppainen J, Minn H, Boström PJ.
11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial).
Cancer Imaging. 2018 Aug 2;18(1):25.
|
| Perez IM, Airola A, Boström PJ, Jambor I, Pahikkala T.
Tournament leave-pair-out cross-validation for receiver operating characteristic analysis.
Stat Methods Med Res. 2018 Aug 20:962280218795190. doi: 10.1177/0962280218795190
|
| Shiradkar R, Ghose S, Jambor I, Taimen P, Ettala O, Purysko AS, Madabhushi A.
Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
J Magn Reson Imaging. 2018 May 7. doi: 10.1002/jmri.26178.
|
| Knaapila J, Kallio H, Hakanen AJ, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Gunell M, Boström PJ.
Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
BJU Int. 2018 Mar 13. doi: 10.1111/bju.14198.
|
| Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, Jambor I, Shnier R, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Purysko AS, Verma S, Ponsky L, Stricker P, Madabhushi A.
Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983.
|
| Jambor I, Kuisma A, Kähkönen E, Kemppainen J, Merisaari H, Eskola O, Teuho J, Perez IM, Pesola M, Aronen H, Boström P, Taimen P, Minn H.
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):355-364.
|
| Knaapila J, Gunell M, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Hakanen AJ, Boström PJ.
Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
Eur Urol Focus. pii: S2405-4569(17)30270-5
|
| Abstracts |
| Merisaari H, Kiviniemi A, Pesola M, Liimataien T, Sucksdorff M, Rissinen E, Airas L, Aronen HJ, Jambor I.
Whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging in healthy volunteers and patients with multiple sclerosis: initial findings. RSNA, Chicago, USA, 2018
|
| Jambor I, Merisaari H, Kiviniemi A, Ettala O, Syvänen K, Kähkönen E, Saunavaara J, Verho J, Boström PJ, Aronen HJ, Taimen P.
Accuracy of IMPROD pre-biopsy biparametric MRI for the detection of prostate cancer in men before their first biopsy: correlation with whole mount prostatectomy sections and implication for focal therapy. RSNA, Chicago, USA, 2018
|
| Movahedi P, Merisaari H, Perez IM, Toivonen J, Taimen P, Boström P, Verho J, Aronen H, Pahikkala T, Jambor I.
Bi-exponential modeling of prostate diffusion weighted MR imaging acquired using high b values: clinical evaluations of advanced post-processing methods. ISMRM, Paris, France, 2018
|
| Perez IM, Toivonen J, Movahedi P, Merisaari H, Verho J, Taimen P, Boström P, Pahikkala T, Aronen H, Jambor I.
Computer aided quantification of prostate cancer diffusion-weighted imaging: repeatability analysis of radiomics as biomarkers for Gleason score prediction. ISMRM, Paris, France, 2018
|
|
Toivonen J, Perez IM, Movahedi P, Merisaari H, Verho J, Taimen P, Boström P, Pahikkala T, Aronen H, Jambor I.
Machine learning for prostate cancer Gleason score prediction using radiomics of T2-weighted imaging, diffusion weighted imaging and T2-mapping. ISMRM, Paris, France, 2018
|
|
Movahedi P, Merisaari H, Laakso H, Perez IM, Liljenbäck H, Aronen H, Minn H, Roivainen A, Liimatainen T, Jambor I.
Spatially constrained mathematical models for diffusion weighted imaging of prostate cancer xenografts in mice: evaluation of therapy response. ISMRM, Paris, France, 2018
|
| 2017 |
| Peer Reviewed Publications |
| Jambor I, Boström PJ, Taimen P, Syvänen K, Kähkönen E, Kallajoki M, Perez IM, Kauko T, Matomaki J, Ettala O, Merisaari H, Kiviniemi A, Dean PB, Aronen HJ.
Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD trial)
J Magn Reson Imaging. 2017 Oct;46(4):1089-1095
|
|
Einarsdottir E, Peyrard-Janvid M, Darki F, Tuulari JJ, Merisaari H, Karlsson L, Scheinin NM, Saunavaara J, Parkkola R, Kantojärvi K, Ämmälä AJ, Yiu-Lin Yu N, Matsson H, Nopola-Hemmi J, Karlsson H, Paunio T, Klingberg T, Leinonen E, Kere J.
Identification of NCAN as a candidate gene for developmental dyslexia. Sci Rep. 2017 Aug 24;7(1):9294.
|
| Ginsburg S, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A.
Radiomic Features for Prostate Cancer Detection on MRI Differ Between the Transition and Peripheral Zones: Preliminary Findings from a Multi-Institutional Study
J Magn Reson Imaging. 2017 Jul;46(1):184-193
|
| Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, Boström PJ,
Pahikkala T, Kiviniemi A, Aronen HJ, Jambor I.
Fitting methods for intravoxel incoherent motion
imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction.
Magn Reson Med. 2017 Mar;77(3):1249-1264.
|
| Conference Publications |
| Perez IM, Toivonen J, Movahedi P, Merisaari H, Pesola M, Taimen P, Boström PJ, Kiviniemi A, Aronen HJ, Pahikkala T, Jambor I.
Diffusion weighted imaging of prostate cancer: Prediction of cancer using texture features from parametric maps of the monoexponential and kurtosis functions,
in 2016 6th International Conference on Image Processing Theory, Tools and Applications, IPTA 2016,
2017 Jan.
|
| Abstracts |
| Jambor I, Movahedi P, Merisaari H, Kemppainen J, Taimen P, Minn H.
Towards improved Gleason score prediction using 18F-FACBC (Fluciclovine) PET and MRI: evaluation of advanced post-processing methods using machine learning. RSNA, Chicago, USA, 2017
|
| Jambor I, Taimen P, Kiviniemi A, Perez IM, Ettala O, Kähkönen E, Syvänen K, Kallajoki M, Boström PJ, Aronen HJ.
Validation of a prospective quantitative evaluation of Gleason score prediction using prostate diffusion weighted imaging: a single institution experience in 293 men with a clinical suspicion of prostate cancer. RSNA, Chicago, USA, 2017
|
| Jambor I, Taimen P, Kiviniemi A, Ettala O, Kähkönen E, Syvänen K, Seppanen M, Oksanen O, Rannikko A, Matikainen M, Riikonen J, Vimpeli S-M, Kallajoki M, Perez IM I, Dean P, Boström PJ, Aronen HJ.
Biparametric MRI and targeted biopsy in men with elevated PSA before their first biopsy: prospective qualitative and quantitative reporting in a multi-institutional registered clinical trial (Multi-IMPROD). RSNA, Chicago, USA, 2017
|
| Jambor I, Kiviniemi A, Taimen P, Ettala O, Kähkönen E, SSyvänen K, Seppanen M, Oksanen O, Rannikko A, Matikainen M, Riikonen J, Vimpeli SM, Kallajoki M, Dean P, Hannu Aronen HJ, Boström PJ.
Development and validation of biparametric MRI followed by targeted biopsy in men with a clinical suspicion of prostate cancer: IMPROD and Multi-IMPROD clinical trials, RSNA, Chicago, USA, 2017
|
| Jambor I, Kemppainen J, Merisaari H, Eskola O, Kähkönen E, Boström PJ, Taimen P, Minn H.
18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial): prostate cancer detection and characterization. ISMRM-SNMMI workshop, Chicago, USA, 2017
|
| Jambor I, Salminen A, Ettala O, Merisaari M, Eskola JV, Koskinen I, Veskimae E, Sairanen J, Minn H, Kemppainen J, Boström PJ.
11C-acetate PET/MRI in bladder cancer staging: ACEBIB trial. ISMRM-SNMMI workshop, Chicago, USA, 2017
|
| 2016 |
| Peer Reviewed Publications |
| Ginsburg S, Taimen P, Merisaari M, Vainio V, Boström PJ, Aronen HJ, Jambor I, Madabhushi A.
Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
J Magn Reson Imaging. 2016 Dec;44(6):1405-1414.
|
| Alinezhad S, Väänänen RM, Tallgrén T, Perez IM, Jambor I, Aronen H, Kähkönen E, Ettala O,
Syvänen K, Nees M, Kallajoki M, Taimen P, Boström PJ, Pettersson K.
Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial
utilizing expression of 11 genes in apparently benign tissue.
Urol Oncol. 2016 Jun;34(6):255.e15-22.
|
| Jambor I, Pesola M, Merisaari H, Taimen P, Boström P, Liimatainen T, Aronen HJ.
Relaxation along fictitious field, diffusion weighted imaging, and T2 mapping of prostate cancer: prediction of cancer aggressiveness.
Magn Reson Med. 2016 May;75(5):2130-40.
|
|
Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander K, Kemppainen J, Kauppila E,
Auren J, Merisaari H, Saunavaara J, Noponen N, Minn H, Aronen HJ, Seppänen M.
Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NaF PET/CT and whole body 1.5T MRI,
including DWI, for the detection of bone metastases in high risk breast and prostate cancer
patients: SKELETA clinical trial. Acta Oncol. 2016 Jan;55(1):59-67.
|
| Jambor I, Pesola M, Liimatainen T, Merisaari H, Boström P, Minn H, Taimen P, Aronen HJ.
Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction.
Magn Reson Med. 2016 Jan;75(1):337-44.
|
| Abstracts |
| Jambor I, Boström PJ, Taimen P, Kähkönen E, Kallajoki M, Kauko T, Perez IM, Ettala O, Merisaari H, Syvänen K, Aronen HJ.
Rapid pre-biopsy MRI in patients with a clinical suspicion of
prostate cancer: results of a controlled prospective registered IMPROD-trial. ISMRM, Singapore, 2016
|
| Kiviniemi A, Merisaari H, Pesola M, Liimatainen T, Aronen HJ, Jambor I.
Whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging in
healthy volunteers: feasibility and initial findings. ISMRM, Singapore, 2016
|
| Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, Boström P, Pahikkala T, Aronen HJ, Jambor I.
Diffusion weighted imaging of prostate cancer: mathematical modeling of signal obtained using low b values.
ISMRM, Singapore, Singapore, 2016
|
| Movahedi P, Hakkarainen H, Merisaari H, Liljenbäck H, Virtanen H, Aronen HJ, Minn H, Poutanen M, Roivainen A, Liimatainen T, Jambor I.
Diffusion weighted imaging of prostate cancer xenografts: comparison of bayesian modeling and independent
least squares fitting. ISMRM, Singapore, 2016
|
| 2015 |
| Peer Reviewed Publications |
| Salminen AP, Jambor I, Syvänen KT, Boström PJ.
Lymph node imaging in bladder cancer. Minerva Urol Nefrol. 2015 Dec 18.
|
| Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Aronen HJ, Jambor I.
Diffusion weighted imaging of prostate cancer: Effect of b-value distribution on repeatability and cancer characterization.
Magn Reson Imaging. 2015 Dec;33(10):1212-8.
|
| Toivonen J, Merisaari H, Pesola M, Taimen P, Boström P, Pahikkala T, Aronen HJ, Jambor I.
Mathematical models for diffusion weighted imaging of prostate cancer using b-values up to 2000 s/mm2:
correlation with Gleason score and repeatability of region of interest analysis. Magn Reson Med. 2015 Oct;74(4):1116-24.
|
| Jambor I, Kähkönen E, Taimen P, Merisaari H, Saunavaara J, Alanen K, Obsitnik B, Minn H, Lehotska V, Aronen HJ.
Pre-biopsy multiparametric 3T prostate MRI in patients with elevated PSA,
normal digital rectal examination and no previous biopsy. J Magn Reson Imaging 2015 May;41(5):1394-404
|
| Jambor I, Merisaari H, Taimen P, Saunavaara J, Alanen K, Boström, Minn H, Pesola M, Aronen HJ.
Evaluation of different mathematical models for diffusion weighted MR imaging of
normal prostate and prostate cancer using high b-values: repeatability study. Magn Reson Med. 2015 May;73(5):1988-98.
|
| Merisaari H, Jambor I.
Optimization of b-value distribution for four mathematical models of prostate cancer diffusion-weighted
imaging using b values up to 2000 s/mm2: simulation and repeatability study. Magn Reson Med. 2015 May;73(5):1954-69.
|
| Abstracts |
| Jambor I, Pesola M, Merisaari H, Taimen P, Boström PJ, Liimatainen T, Aronen HJ.
Relaxation along fictitious field, diffusion weighted imaging, and T2 mapping
of prostate cancer: correlation of quantitative values with Gleason score. ISMRM, Toronto, Canada, 2015
|
| Merisaari H, Hakkarainen H, Liljenbäck H, Ahtinen H, Minn H, Poutanen M Roivainen A, Tiimatainen T, Jambor I.
Evaluation of different mathematical models for diffusion weighted imaging of prostate cancer xenografts in mice.
ISMRM, Toronto, Canada, 2015
|
|
Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala P, Aronen HJ, Jambor I.
Evaluation of b-value distributions for monoexponential model of prostate cancer diffusion-weighted
imaging using b values up to 2000 s/mm2: a repeatability study on region of interest level. ISMRM, Toronto, Canada, 2015
|
| 2014 |
| Peer Reviewed Publications |
|
Jambor I, Merisaari H, Aronen HJ, Järvinen J, Saunavaara J, Kauko T, Borra R, Pesola M.
Optimization of b-value distribution for bioexponential diffusion-weighted MR imaging of normal prostate.
J Magn Reson Imaging. 2014 May;39(5):1213-22.
|
| Abstracts |
|
Jambor I, Boström PJ, Taimen P, Kähkönen E, Kallajoki M, Merisaari H, Saunavaara J, Syvänen K, Aronen HJ.
Pre-biopsy anatomical T2-weighted and diffusion weighted
MR imaging in patients with a clinical suspicion of prostate cancer: IMPROD clinical trial. RSNA, Chicago, USA, 2014
|
|
Merisaari H, Jambor I.
Optimization of b-value distribution for four mathematical models of prostate
cancer diffusion-weighted imaging using b-values up to 2000 s/mm2: simulation and repeatability study. RSNA, Chicago, USA, 2014
|
|
Jambor I, Liimatainen T, Merisaari H, Boström P, Minn H, Aronen HJ, Pesola M.
Rotating frame relaxation imaging of prostate cancer: a feasibility study. ISMRM, Milan, Italy, 2014
|
| Jambor I, Kähkönen E, Taimen P, Saunavaara J, Merisaari H, Alanen K, Obsitnik B, Minn H, Lehotska V, Aronen HJ.
Multiparametric 3T prostate MRI in patients with elevated PSA and no previous biopsy. ISMRM, Milan, Italy, 2014
|
| Hakkarainen H, Jambor I, Poutanen M, Liljenbäck H, Ahtinen H, Roivainen A, Minn H, Martikainen M, Liimatainen Timo.
Rotating frame relaxation measurements in prostate cancer model. ISMRM, Milan, Italy, 2014
|
| 2013 |
| Peer Reviewed Publications |
|
Boccardi M, Bocchetta M, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J, Frisoni GB.
Atypical nucleus accumbens morphology in psychopathy.
another limbic piece in the puzzle. Int J Law Psychitatry 2013;36:157-167.
|
| Toivonen P, Könönen M, Niskanen E, Vaurio O, Repo-Tiihonen E, Aronen HJ, Vanninen R, Tiihonen J, Laakso MP.
Cavum septum pellucidum and psychopathy. Br J Psychiatry 2013;203:152-153.
|
| Kähkönen E, Jambor I, Kemppainen J, Lehtiö K, Silén J, Kuisma J, Luoto P, Tolvanen T, Alanen K, Grönroos T, Kallajoki M, Roivainen A,
Schäfer N, Schibli R, Dragic M, Johayem M, Valencia R, Borkowski S, Minn H.
In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548.
Clin Cancer Res. 2013 Oct 1;19(19):5434-43.
|
| Abstracts |
| Jambor I, Kuisma A, Huovinen R, Sandell M, Auren J, Kajander S, Kemppainen J, Saunavaara
J, Noponen T, Minn H, Aronen HJ, Seppänen M.
Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NaF PET/CT
and whole body 1.5T MRI for detection of bone metastases in high risk breast and prostate cancer patients.
RSNA, Chicago, USA, 2013
|
| Jambor I, Liimatainen T, Paijula J, Boström P, Minn H, Aronen HJ, Pesola M.
Rotating frame RAFF and T1rho imaging of prostate cancer: a feasibility study. ESMRMB, Toulouse, France, 2013
|
|
Jambor I, Kauko T, Merisaari H, Järvinen J, Saunavaara J, Pesola M, Aronen HJ.
Reliability
and repeatability of apparent diffusion coefficient value of normal prostate. ESMRMB, Toulouse, France, 2013
|
|
Merisaari H, Jambor I, Huang X, Han C, Pesola M, Aronen HJ.
Statistical evaluation of different
mathematical models for diffusion weighted imaging of normal prostate: repeatability study. ESMRMB, Toulouse, France, 2013
|
|
Jambor I, Järvinen J, Merisaari H, Aronen HJ, Saunavaara J, Kauko T, Borra R, Pesola M.
Optimization of b-value distribution for biexponential diffusion-weighted MR imaging of normal prostate.
ISMRM, Salt Lake City, USA, 2013
|
| 2012 |
| Peer Reviewed Publications |
|
Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H.
Improved detection of localized prostate cancer using dynamic contrast enhanced MRI and 11C-acetate PET/CT -
correlation with biopsy findings. Eur J Radiol 2012;81:2966-2972.
|
| Abstracts |
|
Jambor I, Borra R, Kemppainen J, Lepomäki V, Dean K, Alanen K, Nurmi M, Aronen HJ, Minn H.
Detection of localized prostate cancer using contrast enhanced MRI and 11C-acetate PET/CT.
ECR, Vienna, Austria, 2012
|
